Statements (27)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:drug
|
gptkbp:bfsLayer |
5
|
gptkbp:bfsParent |
gptkb:paroxetine
|
gptkbp:approves |
gptkb:FDA
gptkb:EMA |
gptkbp:brand |
gptkb:Aropax
gptkb:Paroxetine_hydrochloride gptkb:Paxil |
gptkbp:dosage_form |
gptkb:tablet
oral suspension |
https://www.w3.org/2000/01/rdf-schema#label |
Seroxat
|
gptkbp:ingredients |
gptkb:paroxetine
C19 H20 FN O3 S |
gptkbp:is_part_of |
gptkb:selective_serotonin_reuptake_inhibitors
|
gptkbp:is_used_for |
gptkb:historical_event
gptkb:post-traumatic_stress_disorder anxiety disorders obsessive-compulsive disorder panic disorder |
gptkbp:manufacturer |
gptkb:Glaxo_Smith_Kline
|
gptkbp:side_effect |
dizziness
nausea insomnia dry mouth weight gain sexual dysfunction |
gptkbp:weight |
329.43 g/mol
|